These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23253854)

  • 1. Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy.
    Akintoye SO; Hersh EV
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):251-3. PubMed ID: 23253854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ONJ in two dental practice-based research network regions.
    Fellows JL; Rindal DB; Barasch A; Gullion CM; Rush W; Pihlstrom DJ; Richman J;
    Tex Dent J; 2013 Apr; 130(4):311-8. PubMed ID: 23767160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
    Estilo CL; Van Poznak CH; Wiliams T; Bohle GC; Lwin PT; Zhou Q; Riedel ER; Carlson DL; Schoder H; Farooki A; Fornier M; Halpern JL; Tunick SJ; Huryn JM
    Oncologist; 2008 Aug; 13(8):911-20. PubMed ID: 18695259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy.
    Fleisher KE; Jolly A; Venkata UD; Norman RG; Saxena D; Glickman RS
    J Oral Maxillofac Surg; 2013 Mar; 71(3):513-9. PubMed ID: 22999296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
    Diel IJ; Fogelman I; Al-Nawas B; Hoffmeister B; Migliorati C; Gligorov J; Väänänen K; Pylkkänen L; Pecherstorfer M; Aapro MS
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):198-207. PubMed ID: 17855108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN.
    Barasch A; Cunha-Cruz J; Curro FA; Hujoel P; Sung AH; Vena D; Voinea-Griffin AE; Beadnell S; Craig RG; DeRouen T; Desaranayake A; Gilbert A; Gilbert GH; Goldberg K; Hauley R; Hashimoto M; Holmes J; Latzke B; Leroux B; Lindblad A; Richman J; Safford M; Ship J; Thompson VP; Williams OD; ; Wanrong Y
    Tex Dent J; 2013 Apr; 130(4):299-307. PubMed ID: 23767159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
    Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.
    Fehm T; Beck V; Banys M; Lipp HP; Hairass M; Reinert S; Solomayer EF; Wallwiener D; Krimmel M
    Gynecol Oncol; 2009 Mar; 112(3):605-9. PubMed ID: 19136147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.
    Guarneri V; Miles D; Robert N; Diéras V; Glaspy J; Smith I; Thomssen C; Biganzoli L; Taran T; Conte P
    Breast Cancer Res Treat; 2010 Jul; 122(1):181-8. PubMed ID: 20361252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature.
    Cavanna L; Bertè R; Arcari A; Mordenti P; Pagani R; Vallisa D
    Eur J Intern Med; 2007 Sep; 18(5):417-22. PubMed ID: 17693231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
    Dickinson M; Prince HM; Kirsa S; Zannettino A; Gibbs SD; Mileshkin L; O'Grady J; Seymour JF; Szer J; Horvath N; Joshua DE
    Intern Med J; 2009 May; 39(5):304-16. PubMed ID: 19220531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ; Ramalingam L; Zacharin MR
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.
    Kyrgidis A; Vahtsevanos K; Koloutsos G; Andreadis C; Boukovinas I; Teleioudis Z; Patrikidou A; Triaridis S
    J Clin Oncol; 2008 Oct; 26(28):4634-8. PubMed ID: 18574158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.